Johannes Brägelmann
@braegelmannlab
Followers
117
Following
200
Media
1
Statuses
148
Physician & biostatistician. Excited about cancer research, tumor evolution & functional genomics, driven to improve cancer therapy
Bonn, Deutschland
Joined August 2021
Excited to share our paper on AI-based prediction of disease progression in squamous skin cancers in @Nature_NPJ!. Great collaboration w Juan Pisula & @bozeklab using federated learning & explainable AI for high accuracy while preserving patient privacy: .
nature.com
npj Precision Oncology - Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma
1
4
7
RT @Markuseckstein3: 🚨 New preprint drop! MOSAIC builds a pan-cancer spatial + single-cell multi-omics atlas of thousands of tumors, exposi….
0
10
0
RT @Cancer_Cell: Online Now: CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma .
0
22
0
RT @giannatempopatr: ASCO25 Zelenectide vedotin (BT8009) + pembro: ORR 65% (25% CR) in 1L cis-ineligible la/mUC (incl. PS 2). 👉#bicycle tox….
0
16
0
RT @mike_hannay: Significant data from @niklas_kluemper and team on Zelenectide in heavily pretreated breast cancer patients with Nectin-4….
0
3
0
RT @Markuseckstein3: Happy to share our poster #SABCS24 @SABCSSanAntonio: In heavily pretreated breast cancer from the Phase 1/2 Duravelo-1….
0
10
0
RT @ElizSMcKenna: Now online in @CD_AACR: Sympathetic Neurons Promote Small Cell Lung Cancer Through the β2 Adrenergic Receptor - by Tala,….
0
8
0
RT @Uromigos: 😱 Don't get spooked by new data - watch the #UromigosLive24 panel on novel ADCs in urothelial carcinoma discussed by @tompowl….
0
17
0
RT @DTG_Cologne: Cologne Conference on Lung Cancer June 26-27, 2025. On behalf of the conference chair Caroline Dive and the organizing com….
0
1
0
RT @OncoAlert: Next-generation lung cancer pathology: Development and validation of diagnostic and prognostic algorithms out on @CellCellPr….
0
27
0
RT @niklas_kluemper: Very happy to share our letter published @EUplatinum .➡️Membranous expression of target protein is required for ADC re….
0
12
0
RT @niklas_kluemper: Happy to share our novel manuscript on "Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacitu….
0
12
0
RT @MyriamChalabi: Ecstatic and proud to share the NICHE-2 results, now published in @NEJM. Out of 111 pts, 95% had an MPR , and 68% a pCR….
0
143
0
RT @EpiStrucStab: New hypothesis from our lab! Explore the age-related decline of helicase function and its impact on genome instability. D….
0
8
0
RT @niklas_kluemper: Very exciting! ASCO abstracts on phase EV-202 results have just been released:. Anti-NECTIN4 Enfortumab vedotin with d….
0
7
0
RT @DTG_Cologne: 🔬Join our Department! Apply now for this PostDoc opportunity in cancer genetics, cancer cell biology and cancer immunology….
0
2
0
RT @niklas_kluemper: A lot about anti-NECTIN4 ADC Enfortumab vedotin (EV) beyond UC at #ASCO24! @ASCO . Data of multi-cohort EV-202 (NCT042….
0
5
0
0
1
0
RT @niklas_kluemper: Great review about current developments and future directions for ADCs for NSCLC and breast cancer! @Annals_Oncology @….
0
8
0